Please create a SOAP note for a 34‑year‑old female at her 6‑month hypertension follow‑up on candesartan, including laboratory results, pre‑conception counseling, and the appropriate ICD‑10‑CM codes and CPT code for the visit.

SOAP Note: 34-Year-Old Female, 6-Month Hypertension Follow-Up on Candesartan with Pregnancy Planning

---

SUBJECTIVE

Chief Complaint: 6-month follow-up for hypertension; desires to discuss pregnancy planning.

History of Present Illness:
34-year-old female with chronic hypertension currently managed on candesartan. Reports good medication adherence. Denies headaches, visual changes, chest pain, dyspnea, or edema. Blood pressure readings at home have been stable (patient should specify range if available). Actively planning pregnancy and seeks guidance on medication safety and preconception optimization.

Medications:

• Candesartan [current dose] mg daily

Allergies: [Document any known allergies]

Social History:

• Tobacco: [Yes/No, quantify if applicable]
• Alcohol: [Yes/No, quantify if applicable]
• Illicit drugs: [Yes/No]

Obstetric History: G_P_ [Document gravidity and parity]

---

OBJECTIVE

Vital Signs:

• BP: [Document sitting BP after 15 minutes rest] / [repeat measurement]
• HR: [Document]
• Weight: [Document]
• BMI: [Calculate and document]

Physical Examination:

• General: Well-appearing, no acute distress
• Cardiovascular: Regular rate and rhythm, no murmurs/gallops/rubs
• Lungs: Clear to auscultation bilaterally
• Extremities: No edema
• Fundoscopic exam: [If indicated for long-standing hypertension per 1]

Laboratory Results:

• Basic Metabolic Panel: Creatinine, BUN, electrolytes (Na, K, Cl, CO2)
• Creatinine clearance: [Calculate if not directly measured]
• Urinalysis: Assess for proteinuria
• Fasting glucose or HbA1c
• Lipid panel
• TSH (if not recently checked)
• Complete blood count

---

ASSESSMENT

1. Essential (primary) hypertension, currently controlled on candesartan
2. Preconception counseling for patient with chronic hypertension

---

PLAN

Critical Medication Change Required:

Candesartan must be discontinued immediately and switched to a pregnancy-safe antihypertensive agent. 2, 3 ARBs (including candesartan) are associated with fetal renal anomalies and fetal death and should not be used during pregnancy or in women planning pregnancy 2, 1. The 2020 Hypertension Canada Guidelines explicitly recommend considering discontinuation of ARB therapy before conception 2, and the 2025 AHA/ACC Guidelines classify ARBs as causing harm (Class 3: Harm) in pregnancy 3.

Recommended medication switch:

• First-line options for pregnancy: 2, 3

  • Labetalol (preferred agent)
  • Extended-release nifedipine (long-acting oral formulation)
  • Methyldopa

• Target blood pressure: <140/90 mmHg during pregnancy planning and pregnancy 2, 3

Rationale: These agents have established safety profiles in pregnancy and are recommended as first-line therapy by both Hypertension Canada 2020 2 and AHA/ACC 2025 3 guidelines. Labetalol and extended-release nifedipine are particularly preferred 3.

---

Preconception Counseling Components:

1. Cardiovascular Risk Assessment:

• Assess for target organ damage given chronic hypertension 1:
  • Retinopathy (fundoscopic examination or ophthalmology referral if long-standing hypertension)
  • Renal disease (creatinine, urinalysis for proteinuria, calculate CrCl)
  • Left ventricular hypertrophy (consider ECG or echocardiogram if indicated)

2. Pregnancy-Related Risks Education: 2, 1

• 25% risk of developing superimposed preeclampsia
• Increased risk of preterm birth, placental abruption, intrauterine growth restriction, small for gestational age infants, stillbirth, and maternal renal complications
• Importance of close monitoring throughout pregnancy

3. Aspirin Prophylaxis: 3

• Recommend low-dose aspirin 81 mg daily starting in late first trimester (12-16 weeks) to reduce risk of preeclampsia and its sequelae (Class 1, Level B-R recommendation)

4. Lifestyle Optimization:

• Achieve healthy BMI if overweight/obese
• Regular exercise program
• DASH diet or sodium restriction
• Smoking cessation if applicable
• Limit alcohol consumption

5. Folic Acid Supplementation:

• 400-800 mcg daily starting now (standard preconception recommendation)

6. Additional Laboratory Assessment:

• Review today's labs for any abnormalities requiring correction before pregnancy
• Ensure adequate renal function (important given chronic hypertension)
• Screen for diabetes if not recently done

---

Follow-Up Plan:

Immediate (within 1-2 weeks):

• Recheck BP after medication switch to ensure adequate control on pregnancy-safe agent
• May require dose titration to maintain BP <140/90 mmHg

Ongoing:

• Monthly BP monitoring until pregnancy achieved
• Once pregnant: Close obstetric and medical co-management
• Severe hypertension (≥160/110 mmHg) during pregnancy requires urgent treatment within 30-60 minutes 2, 3

---

Patient Education Provided:

• Explained teratogenic risks of candesartan/ARBs (fetal renal anomalies, fetal death) 2, 1, 4
• Discussed safety of alternative medications during pregnancy
• Reviewed increased pregnancy risks associated with chronic hypertension
• Emphasized importance of preconception BP optimization
• Instructed to notify provider immediately upon positive pregnancy test
• Discussed aspirin prophylaxis timing and rationale
• Provided written educational materials on hypertension in pregnancy

---

Prescriptions:

1. DISCONTINUE: Candesartan
2. START: [Labetalol/Extended-release nifedipine/Methyldopa] [specify dose]
3. START: Folic acid 400-800 mcg daily
4. PLAN TO START: Aspirin 81 mg daily (once pregnancy confirmed, beginning 12-16 weeks gestation)

---

Referrals:

• Obstetrics: For preconception consultation and pregnancy planning
• Ophthalmology: If fundoscopic exam concerning or unable to perform adequate examination (for long-standing hypertension assessment) 1
• Maternal-Fetal Medicine: Consider if additional risk factors present or if BP difficult to control

---

ICD-10-CM CODES

• I10 - Essential (primary) hypertension
• Z31.69 - Other general counseling and advice on procreation (preconception counseling)
• Z79.899 - Other long-term (current) drug therapy (for antihypertensive medication)

---

CPT CODE

• 99214 - Office or other outpatient visit, established patient, 30-39 minutes (moderate complexity medical decision-making: chronic condition with medication change, preconception counseling, laboratory review)
  • Alternative: 99215 if visit duration 40-54 minutes or high complexity given extensive counseling and coordination of care

---

COMMON PITFALLS TO AVOID:

1. Do not delay ARB discontinuation - Switch immediately, not "when pregnancy confirmed" 2. First-trimester exposure carries teratogenic risk.

2. Do not use atenolol as alternative beta-blocker - Associated with lower birth weight 1. Labetalol is the preferred beta-blocker for pregnancy.

3. Do not undertarget BP - Maintain <140/90 mmHg throughout preconception and pregnancy period 2, 3. Severe hypertension (≥160/110 mmHg) is an obstetrical emergency 2.

4. Do not forget aspirin counseling - This is a Class 1 recommendation that significantly reduces preeclampsia risk 3.

5. Do not assume patient understands risks - Explicitly document discussion of 25% superimposed preeclampsia risk and other maternal-fetal complications 2.